Home/Filings/4/0001628280-23-040674
4//SEC Filing

Phillips Geraint 4

Accession 0001628280-23-040674

CIK 0000834365other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 7:14 PM ET

Size

6.5 KB

Accession

0001628280-23-040674

Insider Transaction Report

Form 4
Period: 2023-11-19
Phillips Geraint
SVP, Global Operations
Transactions
  • Award

    Common Stock

    2023-11-19+23459,890 total
  • Sale

    Common Stock

    2023-12-01$12.37/sh303$3,74859,587 total
Footnotes (2)
  • [F1]The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.
  • [F2]The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Issuer

BIOLIFE SOLUTIONS INC

CIK 0000834365

Entity typeother

Related Parties

1
  • filerCIK 0001960665

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 7:14 PM ET
Size
6.5 KB